274 related articles for article (PubMed ID: 11469904)
1. Prophylaxis against Staphylococcus aureus vascular graft infection with mupirocin-soaked, collagen-sealed dacron.
Ghiselli R; Giacometti A; Goffi L; Cirioni O; Mocchegiani F; Orlando F; Paggi AM; Petrelli E; Scalise G; Saba V
J Surg Res; 2001 Aug; 99(2):316-20. PubMed ID: 11469904
[TBL] [Abstract][Full Text] [Related]
2. The prophylactic efficacy of rifampicin-soaked graft in combination with systemic vancomycin in the prevention of prosthetic vascular graft infection: an experimental study.
Sacar M; Goksin I; Baltalarli A; Turgut H; Sacar S; Onem G; Ozcan V; Adali F
J Surg Res; 2005 Dec; 129(2):329-34. PubMed ID: 16360378
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of rifampin-levofloxacin as a prophylactic agent in preventing Staphylococcus epidermidis graft infection.
Ghiselli R; Giacometti A; Goffi L; Cirioni O; Boccoli G; Mocchegiani F; Riva A; Scalise G; Saba V
Eur J Vasc Endovasc Surg; 2000 Dec; 20(6):508-11. PubMed ID: 11136585
[TBL] [Abstract][Full Text] [Related]
4. Linezolid alone and in combination with rifampicin prevents experimental vascular graft infection due to methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis.
Sacar M; Sacar S; Kaleli I; Onem G; Turgut H; Goksin I; Ozcan V; Kaan Inan B; Duver H; Baltalarli A
J Surg Res; 2007 May; 139(2):170-5. PubMed ID: 17292421
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic efficacy of topical temporin A and RNAIII-inhibiting peptide in a subcutaneous rat Pouch model of graft infection attributable to staphylococci with intermediate resistance to glycopeptides.
Cirioni O; Giacometti A; Ghiselli R; Dell'Acqua G; Gov Y; Kamysz W; Lukasiak J; Mocchegiani F; Orlando F; D'Amato G; Balaban N; Saba V; Scalise G
Circulation; 2003 Aug; 108(6):767-71. PubMed ID: 12885754
[TBL] [Abstract][Full Text] [Related]
6. RNAIII-inhibiting peptide and/or nisin inhibit experimental vascular graft infection with methicillin-susceptible and methicillin-resistant Staphylococcus epidermidis.
Ghiselli R; Giacometti A; Cirioni O; Dell'Acqua G; Mocchegiani F; Orlando F; D'Amato G; Rocchi M; Scalise G; Saba V
Eur J Vasc Endovasc Surg; 2004 Jun; 27(6):603-7. PubMed ID: 15121110
[TBL] [Abstract][Full Text] [Related]
7. Vascular graft infection by Staphylococcus aureus: efficacy of cefazolin, teicoplanin and vancomycin prophylaxis protocols in a rat model.
Atahan E; Gul M; Ergun Y; Eroglu E
Eur J Vasc Endovasc Surg; 2007 Aug; 34(2):182-7. PubMed ID: 17481929
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of vancomycin, teicoplanin and fusidic acid as prophylactic agents in prevention of vascular graft infection: an experimental study in rat.
Yasim A; Gul M; Atahan E; Ciragil P; Aral M; Ergun Y
Eur J Vasc Endovasc Surg; 2006 Mar; 31(3):274-9. PubMed ID: 16360328
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of mupirocin and amoxicillin-clavulanate alone and in combination against staphylococci including those resistant to methicillin.
Alou L; Cafini F; Sevillano D; Unzueta I; Prieto J
Int J Antimicrob Agents; 2004 May; 23(5):513-6. PubMed ID: 15120734
[TBL] [Abstract][Full Text] [Related]
10. Gelatin-sealed dacron graft is not more susceptible to MRSA infection than PTFE graft.
Yasim A; Gul M; Ciralik H; Ergun Y
Eur J Vasc Endovasc Surg; 2006 Oct; 32(4):425-30. PubMed ID: 16725356
[TBL] [Abstract][Full Text] [Related]
11. Systemic and local antibiotic prophylaxis in the prevention of Staphylococcus epidermidis graft infection.
Turgut H; Sacar S; Kaleli I; Sacar M; Goksin I; Toprak S; Asan A; Cevahir N; Tekin K; Baltalarli A
BMC Infect Dis; 2005 Oct; 5():91. PubMed ID: 16242027
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of collagen silver-coated polyester and rifampin-soaked vascular grafts to resist infection from MRSA and Escherichia coli in a dog model.
Schneider F; O'Connor S; Becquemin JP
Ann Vasc Surg; 2008 Nov; 22(6):815-21. PubMed ID: 18835516
[TBL] [Abstract][Full Text] [Related]
13. [Experimental examination concerning the efficacy of silver-coated Dacron prostheses in vascular graft infections following subcutaneous implantation in a standardized infection model].
Hernández-Richter T; Wittmann F; Mayr S; Schmitt-Sody M; Blasenbreu S; Wichmann M; Heiss MM; Schardey HM; Angele MK
Zentralbl Chir; 2003 Mar; 128(3):244-9. PubMed ID: 12739511
[TBL] [Abstract][Full Text] [Related]
14. Mupirocin prophylaxis against methicillin-susceptible, methicillin-resistant, or vancomycin-intermediate Staphylococcus epidermidis vascular-graft infection.
Giacometti A; Cirioni O; Ghiselli R; Goffi L; Viticchi C; Mocchegiani F; Riva A; Orlando F; Saba V; Scalise G
Antimicrob Agents Chemother; 2000 Oct; 44(10):2842-4. PubMed ID: 10991868
[TBL] [Abstract][Full Text] [Related]
15. Polycationic peptides as prophylactic agents against methicillin-susceptible or methicillin-resistant Staphylococcus epidermidis vascular graft infection.
Giacometti A; Cirioni O; Ghiselli R; Goffi L; Mocchegiani F; Riva A; Scalise G; Saba V
Antimicrob Agents Chemother; 2000 Dec; 44(12):3306-9. PubMed ID: 11083632
[TBL] [Abstract][Full Text] [Related]
16. Does in situ replacement of a staphylococcal infected vascular graft with a rifampicin impregnated gelatin sealed Dacron graft reduce the incidence of subsequent infection?
Vicaretti M; Hawthorne W; Ao PY; Fletcher JP
Int Angiol; 1999 Sep; 18(3):225-32. PubMed ID: 10688422
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic efficacy of linezolid alone or combined with levofloxacin and vancomycin in a rat subcutaneous pouch model of graft infection caused by Staphylococcus epidermidis with intermediate resistance to glycopeptides.
Giacometti A; Ghiselli R; Cirioni O; Mocchegiani F; Orlando F; Del Prete MS; D'Amato G; Silvestri C; Saba V; Scalise G
J Antimicrob Chemother; 2003 Oct; 52(4):724-6. PubMed ID: 12951347
[TBL] [Abstract][Full Text] [Related]
18. The lipopeptides Pal-Lys-Lys-NH(2) and Pal-Lys-Lys soaking alone and in combination with intraperitoneal vancomycin prevent vascular graft biofilm in a subcutaneous rat pouch model of staphylococcal infection.
Cirioni O; Giacometti A; Ghiselli R; Kamysz W; Silvestri C; Orlando F; Mocchegiani F; Vittoria AD; Kamysz E; Saba V; Scalise G
Peptides; 2007 Jun; 28(6):1299-303. PubMed ID: 17537542
[TBL] [Abstract][Full Text] [Related]
19. Does in situ replacement of a staphylococcal infected vascular graft with a rifampicin impregnated gelatin sealed Dacron graft reduce the incidence of subsequent infection?
Vicaretti M; Hawthorne W; Ao PY; Fletcher JP
Int Angiol; 2000 Jun; 19(2):158-65. PubMed ID: 10905800
[TBL] [Abstract][Full Text] [Related]
20. [Vascular graft infection by Staphylococcus epidermidis: efficacy of various perioperative prophylaxis protocols in an animal model].
Giacometti A; Cirioni O; Ghiselli R; Mocchegiani F; Riva A; Saba V; Scalise G
Infez Med; 2001 Mar; 9(1):13-8. PubMed ID: 12082344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
